Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Directorate Change

19 Dec 2008 07:01

RNS Number : 4235K
Stanelco PLC
19 December 2008
 



19 December 2008

Stanelco plc ('Stanelco' or 'the Company')

Appointment of Group Finance Director

The Board of Directors (the 'Board') of Stanelco, the Bioplastics and Radio Frequency (RF) technology business, is pleased to announce the appointment of Susan "Sue" Bygrave, aged 43, as Group Finance Director and member of the Board with effect from 5 January 2009.

Prior to joining Stanelco, Sue held the position of Group Finance Director of VEGA Group plc ("VEGA"), the specialist professional services group providing clients with consulting, technology and managed solutions business. VEGA floated on the London Stock Exchange in 1992 and was listed on the FTSE Fledgling Index (Software and Computer Services classification) and the FTSE techMark Index. Following flotation, VEGA achieved growth both organically and by acquisition, until it was acquired in February 2008, by Finmeccanica SpA for £62m, and consequently de-listed.

Prior to this, Sue worked for Mettoni Group plc, DCS Group plc and KPMG with whom she qualified as a chartered accountant.

John Standen, Chairman of Stanelco, commented:

"Sue joins Stanelco at an exciting time and we are delighted to welcome her. The Board is confident that Sue's pragmatic approach and proven track-record in organic and acquisitive growth, as well as her established plc experience, will be invaluable at this important stage of Stanelco's pursuit of significant growth in the bioplastics sector".

Sue Bygrave, incoming Group Finance Director of Stanelco, commented:

"I am delighted to be joining Stanelco at this exciting time in its evolution and I look forward to working with the Board as we pursue the market opportunities and grow the business."

Further information on Ms Susan Jane Bygrave is set out below:

Sue Bygrave's directorships in the last five years (from which she has now resigned) comprise VEGA Group plc and Mettoni Group plc. In July 2002, while Sue Bygrave was a Director of the company, Mettoni Group plc was placed into administrative receivership.

Sue Bygrave does not have an interest in the ordinary shares of the Company.

Other than the information contained in this announcement, there are no other matters to be disclosed under paragraph 9.6.13R of the Listing Rules.

For further information please contact:

Paul Mines, Chief Executive, Stanelco 

Tel: +44 (0) 2380 867100

Jonathon Brill/Caroline Stewart

Financial Dynamics

Tel: +44 (0) 20 7831 3113

About Stanelco 

Stanelco is a market-leading British technology company at the forefront of development and commercialisation of bioplastics. Stanelco produces a biodegradable and sustainable range of products under the Bioplast brand. Such products are capable of replacing conventional oil-based plastics and have diverse application including flexible films, moulded products, extruded sheets and food wraps. In addition, Stanelco's separate Radio Frequency (RF) division has worldwide renown in the design and install of specialist RF furnaces, welders and induction equipment.

 

Stanelco already has some 200 patents and its future success relies on the expertise of its highly qualified commercial, research and development teams that are focusing on the invention and industrialisation of new biopolymer-based resins and on delivering products with ever greater functionality and sustainability.

Ends

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATPBFTMMMBBJP
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.